Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 9, 1996 - Issue 4
26
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

To Inhibit the Osteoclast or to Stimulate the Osteoblast?

, MD (Internist)
Pages 35-36 | Published online: 28 Jan 2018

References

  • Steiniche T, Hasling C, Charles P, Eriksen EF, Mosekilde L, Meisen F: A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. Bone 1989; 10: 313–320.
  • Heaney RP, Recker RR, Saville PD: Menopausal changes in calcium balance performance. J Lab Clin Med 1978; 92: 953–963.
  • Nordin BE, Polley KJ: Metabolic consequences of the menopause: a cross-sectional, longitudinal, and intervention study on 557 normal postmenopausal women. Calcif Tissue Int 1987; 41 (Suppl 1): 51–59.
  • Lindsay R, Cosman F, Herrington BS, Himmelstein S: Bone mass and body composition in normal women. J Bone Miner Res 1992; 7: 55–63.
  • Raisz LG, Wiita B, Artis A, Bowen A, Schwartz S, Trahiotis M, Shoukri K, Smith J: Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab 1996; 81: 37–43.
  • Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, Carbone PP, DeMets DL: Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 1992; 326: 852–856.
  • Riggs BL, Hodgson SF, O'Fallon WM, Chao EY, Wahner HW, Muhs JH, Cedel SL, Melton LJ III: Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990; 322: 802–809.
  • Overgaard K, Hansen MA, Jensen SB, Christiansen C: Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. BMJ 1992; 305: 556–561.
  • Kanis JA, Johnell O, Gullberg B, Allander E, Dilsen G, Gennari C, Lopes Vaz AA, Lyritis GP, Mazzuoli G, Miravet L, Passeri M, Cano RP, Rapado A, Ribot C: Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. BMJ 1992; 305: 1124–1128.
  • Riggs BL, Hodgson SF, O'Fallon WM, Chao EY, Wahner HW, Muhs JM, Cedel SL, Melton LJ III: Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990; 322: 802–809.
  • Pak CY, Sakhaee K, Adams-Huet B, Piziak V, Peterson RD, Poindexter JR: Treatment of postmenopausal osteoporosis with slow-release sodium fluoride: final report of a randomized controlled trial. Ann Intern Med 1995; 123: 401–408.
  • Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF: Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest 1979; 64: 729–736.
  • Price PA, Baukol SA: 1,25-Dihydroxyvitamin D3 increases serum levels of the vitamin K-dependent bone protein. Biochem Biophys Res Commun 1981; 99: 928–935.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.